107 related articles for article (PubMed ID: 15585414)
1. Genetically engineered dopamine beta-hydroxylase gene promoters with better PHOX2-binding sites drive significantly enhanced transgene expression in a noradrenergic cell-specific manner.
Hwang DY; Hwang MM; Kim HS; Kim KS
Mol Ther; 2005 Jan; 11(1):132-41. PubMed ID: 15585414
[TBL] [Abstract][Full Text] [Related]
2. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
3. A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons.
Hwang DY; Carlezon WA; Isacson O; Kim KS
Hum Gene Ther; 2001 Sep; 12(14):1731-40. PubMed ID: 11560767
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of the promoter region of the human Phox2b gene.
Jong Hong S; Chae H; Kim KS
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):29-39. PubMed ID: 15193420
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites.
Kim HS; Seo H; Yang C; Brunet JF; Kim KS
J Neurosci; 1998 Oct; 18(20):8247-60. PubMed ID: 9763470
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional targeting to brain cells: Engineering cell type-specific promoter containing cassettes for enhanced transgene expression.
Boulaire J; Balani P; Wang S
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):589-602. PubMed ID: 19394380
[TBL] [Abstract][Full Text] [Related]
7. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
8. Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene.
Yang C; Kim HS; Seo H; Kim CH; Brunet JF; Kim KS
J Neurochem; 1998 Nov; 71(5):1813-26. PubMed ID: 9798905
[TBL] [Abstract][Full Text] [Related]
9. Towards endothelial cell-specific transgene expression in pigs: characterization of the pig ICAM-2 promoter.
Godwin JW; Fisicaro N; d'Apice AJ; Cowan PJ
Xenotransplantation; 2006 Nov; 13(6):514-21. PubMed ID: 17059578
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
[TBL] [Abstract][Full Text] [Related]
11. Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model.
Campbell SE; Bennett D; Nasir L; Gault EA; Argyle DJ
Rheumatology (Oxford); 2005 Jun; 44(6):735-43. PubMed ID: 15757961
[TBL] [Abstract][Full Text] [Related]
12. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
13. A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene.
Kim CH; Hwang DY; Park JJ; Kim KS
J Neurosci; 2002 Apr; 22(7):2579-89. PubMed ID: 11923423
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
15. The promoter of brain-specific angiogenesis inhibitor 1-associated protein 4 drives developmentally targeted transgene expression mainly in adult cerebral cortex and hippocampus.
Kim MY; Ahn KY; Lee SM; Koh JT; Chun BJ; Bae CS; Lee KS; Kim KK
FEBS Lett; 2004 May; 566(1-3):87-94. PubMed ID: 15147874
[TBL] [Abstract][Full Text] [Related]
16. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
18. Phox2 and dHAND transcription factors select shared and unique target genes in the noradrenergic cell type.
Rychlik JL; Hsieh M; Eiden LE; Lewis EJ
J Mol Neurosci; 2005; 27(3):281-92. PubMed ID: 16280598
[TBL] [Abstract][Full Text] [Related]
19. Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression.
Lonergan T; Teschemacher AG; Hwang DY; Kim KS; Pickering AE; Kasparov S
Physiol Genomics; 2005 Jan; 20(2):165-72. PubMed ID: 15561757
[TBL] [Abstract][Full Text] [Related]
20. Neuronal cell type-specific promoter of the alpha CaM kinase II gene is activated by Zic2, a Zic family zinc finger protein.
Sakurada T; Mima K; Kurisaki A; Sugino H; Yamauchi T
Neurosci Res; 2005 Nov; 53(3):323-30. PubMed ID: 16157407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
